Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Biosimilars
Revenue, means the sales value of Biosimilars
This report studies sales (consumption) of Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilars in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Antibody
Hormone
Growth Factors
Others
Split by application, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Europe Biosimilars Market Report 2016
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Antibody
1.2.2 Hormone
1.2.3 Growth Factors
1.2.4 Others
1.3 Application of Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Others
1.4 Biosimilars Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Biosimilars (2011-2021)
1.5.1 Europe Biosimilars Sales and Growth Rate (2011-2021)
1.5.2 Europe Biosimilars Revenue and Growth Rate (2011-2021)
2 Europe Biosimilars by Manufacturers, Type and Application
2.1 Europe Biosimilars Market Competition by Manufacturers
2.1.1 Europe Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Biosimilars (Volume and Value) by Type
2.2.1 Europe Biosimilars Sales and Market Share by Type (2011-2016)
2.2.2 Europe Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Europe Biosimilars (Volume and Value) by Countries
2.3.1 Europe Biosimilars Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Biosimilars Revenue and Market Share by Countries (2011-2016)
2.4 Europe Biosimilars (Volume) by Application
3 Germany Biosimilars (Volume, Value and Sales Price)
3.1 Germany Biosimilars Sales and Value (2011-2016)
3.1.1 Germany Biosimilars Sales and Growth Rate (2011-2016)
3.1.2 Germany Biosimilars Revenue and Growth Rate (2011-2016)
3.1.3 Germany Biosimilars Sales Price Trend (2011-2016)
3.2 Germany Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Biosimilars Sales and Market Share by Type
3.4 Germany Biosimilars Sales and Market Share by Application
4 France Biosimilars (Volume, Value and Sales Price)
4.1 France Biosimilars Sales and Value (2011-2016)
4.1.1 France Biosimilars Sales and Growth Rate (2011-2016)
4.1.2 France Biosimilars Revenue and Growth Rate (2011-2016)
4.1.4 France Biosimilars Sales Price Trend (2011-2016)
4.2 France Biosimilars Sales and Market Share by Manufacturers
4.3 France Biosimilars Sales and Market Share by Type
4.4 France Biosimilars Sales and Market Share by Application
5 UK Biosimilars (Volume, Value and Sales Price)
5.1 UK Biosimilars Sales and Value (2011-2016)
5.1.1 UK Biosimilars Sales and Growth Rate (2011-2016)
5.1.2 UK Biosimilars Revenue and Growth Rate (2011-2016)
5.1.5 UK Biosimilars Sales Price Trend (2011-2016)
5.2 UK Biosimilars Sales and Market Share by Manufacturers
5.3 UK Biosimilars Sales and Market Share by Type
5.4 UK Biosimilars Sales and Market Share by Application
6 Russia Biosimilars (Volume, Value and Sales Price)
6.1 Russia Biosimilars Sales and Value (2011-2016)
6.1.1 Russia Biosimilars Sales and Growth Rate (2011-2016)
6.1.2 Russia Biosimilars Revenue and Growth Rate (2011-2016)
6.1.6 Russia Biosimilars Sales Price Trend (2011-2016)
6.2 Russia Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Biosimilars Sales and Market Share by Type
6.4 Russia Biosimilars Sales and Market Share by Application
7 Italy Biosimilars (Volume, Value and Sales Price)
7.1 Italy Biosimilars Sales and Value (2011-2016)
7.1.1 Italy Biosimilars Sales and Growth Rate (2011-2016)
7.1.2 Italy Biosimilars Revenue and Growth Rate (2011-2016)
7.1.7 Italy Biosimilars Sales Price Trend (2011-2016)
7.2 Italy Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Biosimilars Sales and Market Share by Type
7.4 Italy Biosimilars Sales and Market Share by Application
8 Spain Biosimilars (Volume, Value and Sales Price)
8.1 Spain Biosimilars Sales and Value (2011-2016)
8.1.1 Spain Biosimilars Sales and Growth Rate (2011-2016)
8.1.2 Spain Biosimilars Revenue and Growth Rate (2011-2016)
8.1.8 Spain Biosimilars Sales Price Trend (2011-2016)
8.2 Spain Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Biosimilars Sales and Market Share by Type
8.4 Spain Biosimilars Sales and Market Share by Application
9 Benelux Biosimilars (Volume, Value and Sales Price)
9.1 Benelux Biosimilars Sales and Value (2011-2016)
9.1.1 Benelux Biosimilars Sales and Growth Rate (2011-2016)
9.1.2 Benelux Biosimilars Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Biosimilars Sales Price Trend (2011-2016)
9.2 Benelux Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Biosimilars Sales and Market Share by Type
9.4 Benelux Biosimilars Sales and Market Share by Application
10 Europe Biosimilars Manufacturers Analysis
10.1 Roche
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Biosimilars Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Amgen
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Biosimilars Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 AbbVie
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Biosimilars Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Sanofi-Aventis
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Biosimilars Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Johnson & Johnson
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Biosimilars Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Pfizer
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Biosimilars Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Biosimilars Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Eli Lilly
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Biosimilars Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Novartis
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Biosimilars Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Merck
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Biosimilars Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 3sbio
10.12 Changchun High Tech
10.13 CP Guojian
10.14 Biotech
10.15 Gelgen
10.16 Innovent
11 Biosimilars Manufacturing Cost Analysis
11.1 Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilars
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Biosimilars Market Forecast (2016-2021)
14.1 Germany Biosimilars Sales Forecast (2016-2021)
14.2 France Biosimilars Sales Forecast (2016-2021)
14.3 UK Biosimilars Sales Forecast (2016-2021)
14.4 Russia Biosimilars Sales Forecast (2016-2021)
14.5 Italy Biosimilars Sales Forecast (2016-2021)
14.6 Spain Biosimilars Sales Forecast (2016-2021)
14.7 Benelux Biosimilars Sales Forecast (2016-2021)
14.8 Europe Biosimilars Sales Forecast by Type (2016-2021)
14.9 Europe Biosimilars Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Type in 2015
Figure Antibody Picture
Figure Hormone Picture
Figure Growth Factors Picture
Figure Others Picture
Table Application of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Others Examples
Figure Germany Biosimilars Revenue and Growth Rate (2011-2021)
Figure France Biosimilars Revenue and Growth Rate (2011-2021)
Figure UK Biosimilars Revenue and Growth Rate (2011-2021)
Figure Russia Biosimilars Revenue and Growth Rate (2011-2021)
Figure Italy Biosimilars Revenue and Growth Rate (2011-2021)
Figure Spain Biosimilars Revenue and Growth Rate (2011-2021)
Figure Benelux Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Biosimilars Sales and Growth Rate (2011-2021)
Figure Europe Biosimilars Revenue and Growth Rate (2011-2021)
Table Europe Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table Europe Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Biosimilars Revenue Share by Manufacturers
Table Europe Biosimilars Sales and Market Share by Type (2011-2016)
Table Europe Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Biosimilars by Type (2011-2016)
Figure Europe Biosimilars Sales Growth Rate by Type (2011-2016)
Table Europe Biosimilars Revenue and Market Share by Type (2011-2016)
Table Europe Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilars by Type (2011-2016)
Figure Europe Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Europe Biosimilars Sales and Market Share by Countries (2011-2016)
Table Europe Biosimilars Sales Share by Countries (2011-2016)
Figure Sales Market Share of Biosimilars by Countries (2011-2016)
Table Europe Biosimilars Revenue and Market Share by Countries (2011-2016)
Table Europe Biosimilars Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Biosimilars by Countries (2011-2016)
Table Europe Biosimilars Sales and Market Share by Application (2011-2016)
Table Europe Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Biosimilars by Application (2011-2016)
Figure Germany Biosimilars Sales and Growth Rate (2011-2016)
Figure Germany Biosimilars Revenue and Growth Rate (2011-2016)
Figure Germany Biosimilars Sales Price Trend (2011-2016)
Table Germany Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Biosimilars Sales by Type (2015 and 2016)
Table Germany Biosimilars Market Share by Type (2015 and 2016)
Table Germany Biosimilars Sales by Application (2015 and 2016)
Table Germany Biosimilars Market Share by Application (2015 and 2016)
Figure France Biosimilars Sales and Growth Rate (2011-2016)
Figure France Biosimilars Revenue and Growth Rate (2011-2016)
Figure France Biosimilars Sales Price Trend (2011-2016)
Table France Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Biosimilars Sales by Type (2015 and 2016)
Table France Biosimilars Market Share by Type (2015 and 2016)
Table France Biosimilars Sales by Application (2015 and 2016)
Table France Biosimilars Market Share by Application (2015 and 2016)
Figure UK Biosimilars Sales and Growth Rate (2011-2016)
Figure UK Biosimilars Revenue and Growth Rate (2011-2016)
Figure UK Biosimilars Sales Price Trend (2011-2016)
Table UK Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Biosimilars Sales by Type (2015 and 2016)
Table UK Biosimilars Market Share by Type (2015 and 2016)
Table UK Biosimilars Sales by Application (2015 and 2016)
Table UK Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Biosimilars Sales and Growth Rate (2011-2016)
Figure Russia Biosimilars Revenue and Growth Rate (2011-2016)
Figure Russia Biosimilars Sales Price Trend (2011-2016)
Table Russia Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Biosimilars Sales by Type (2015 and 2016)
Table Russia Biosimilars Market Share by Type (2015 and 2016)
Table Russia Biosimilars Sales by Application (2015 and 2016)
Table Russia Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Biosimilars Sales and Growth Rate (2011-2016)
Figure Italy Biosimilars Revenue and Growth Rate (2011-2016)
Figure Italy Biosimilars Sales Price Trend (2011-2016)
Table Italy Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Biosimilars Sales by Type (2015 and 2016)
Table Italy Biosimilars Market Share by Type (2015 and 2016)
Table Italy Biosimilars Sales by Application (2015 and 2016)
Table Italy Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Biosimilars Sales and Growth Rate (2011-2016)
Figure Spain Biosimilars Revenue and Growth Rate (2011-2016)
Figure Spain Biosimilars Sales Price Trend (2011-2016)
Table Spain Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Biosimilars Sales by Type (2015 and 2016)
Table Spain Biosimilars Market Share by Type (2015 and 2016)
Table Spain Biosimilars Sales by Application (2015 and 2016)
Table Spain Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Biosimilars Sales and Growth Rate (2011-2016)
Figure Benelux Biosimilars Revenue and Growth Rate (2011-2016)
Figure Benelux Biosimilars Sales Price Trend (2011-2016)
Table Benelux Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Biosimilars Sales by Type (2015 and 2016)
Table Benelux Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Biosimilars Sales by Application (2015 and 2016)
Table Benelux Biosimilars Market Share by Application (2015 and 2016)
Table Biosimilars Basic Information List
Table Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biosimilars Sales Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biosimilars Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biosimilars Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Biosimilars Sales Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3sbio Biosimilars Sales Market Share (2011-2016)
Table Changchun High Tech Basic Information List
Table Changchun High Tech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun High Tech Biosimilars Sales Market Share (2011-2016)
Table CP Guojian Basic Information List
Table CP Guojian Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Guojian Biosimilars Sales Market Share (2011-2016)
Table Biotech Basic Information List
Table Biotech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotech Biosimilars Sales Market Share (2011-2016)
Table Gelgen Basic Information List
Table Gelgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gelgen Biosimilars Sales Market Share (2011-2016)
Table Innovent Basic Information List
Table Innovent Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Innovent Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure Germany Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Germany Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure France Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure France Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure UK Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure UK Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Russia Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Italy Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Spain Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Europe Biosimilars Sales Forecast by Type (2016-2021)
Table Europe Biosimilars Sales Forecast by Application (2016-2021)
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...